Bids Are Invited For Price Registration For The Acquisition Of Group Ix Oncology Medicines

Price Registration For The Acquisition Of Group Ix Oncology Medicines. Abiraterone Acetate,Abiraterone Acetate,Zoledronic Acid,Anastrozole,Apalutamide,Apalutamide,Axitinib,Axitinib,Azacitidine,Bevacizumab,Bevacizumab,Bevacizumab,Bicalutamide,Bleomycin Sulfate,Bortezomib,Cabazitaxel,Capecitabine,Capecitabine,Carboplatin,Carboplatin,Cyproterone Acetate,Cetuximab,Cetuximab,Cyclophosphamide,Cisplatin,Cytarabine,Dacarbazine,Docetaxel,Docetaxel,Doxorubicin Hydrochloride,Doxorubicin Hcl Hydrochloride, Goserelin Acetate, Goserelin Acetate, Goserelin Acetate, Goserelin Acetate, Hydroxyurea, Ifosfamide, Irinotecan Hydrochloride, Lanreotide Acetate, Lapatinib, Letrozole, Leuprorelin Acetate, Leuprorelin Acetate, Megestrol Acetate,Mesna,Mesna,Methotrexate,Octreotide,Octreotide,Octreotide,Oxaliplatin,Oxaliplatin,Paclitaxel,Paclitaxel,Pamidronate Sodium,Panitumumab,Panitumumab,Pazopanib,Pazopanib,Pembrolizumab,Pembrolizumab,Pemetrexed,Ribociclib,Ribociclib,Sorafenib Tosylate,Sunitinib,Tamoxifen Citrate, Temozolomide, Temozolomide, Temozolomide, Trastuzumab, Trastuzumab, Trastuzumab, Vinblastine, Vincristine, Vinorelbine, Vinorelbine